| Home > Publications Database > Limbic encephalitis with mGluR5 antibodies and immunotherapy-responsive prosopagnosia. |
| Journal Article | DZNE-2020-03974 |
; ; ; ; ; ; ; ; ;
2014
Ovid
[S.l.]
This record in other databases:
Please use a persistent id in citations: doi:10.1212/WNL.0000000000000865
Keyword(s): Adult (MeSH) ; Autoantibodies: blood (MeSH) ; Autoantibodies: cerebrospinal fluid (MeSH) ; Female (MeSH) ; Humans (MeSH) ; Immunoglobulin G: blood (MeSH) ; Immunoglobulin G: cerebrospinal fluid (MeSH) ; Limbic Encephalitis: blood (MeSH) ; Limbic Encephalitis: cerebrospinal fluid (MeSH) ; Limbic Encephalitis: complications (MeSH) ; Limbic Encephalitis: drug therapy (MeSH) ; Limbic Encephalitis: immunology (MeSH) ; Limbic Encephalitis: therapy (MeSH) ; Methylprednisolone: therapeutic use (MeSH) ; Plasma Exchange (MeSH) ; Prosopagnosia: blood (MeSH) ; Prosopagnosia: cerebrospinal fluid (MeSH) ; Prosopagnosia: complications (MeSH) ; Prosopagnosia: drug therapy (MeSH) ; Prosopagnosia: immunology (MeSH) ; Prosopagnosia: therapy (MeSH) ; Receptor, Metabotropic Glutamate 5: drug effects (MeSH) ; Receptor, Metabotropic Glutamate 5: immunology (MeSH) ; Autoantibodies ; GRM5 protein, human ; Immunoglobulin G ; Receptor, Metabotropic Glutamate 5 ; Methylprednisolone
|
The record appears in these collections: |